172 related articles for article (PubMed ID: 25680347)
1. [Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].
Wand K; Abraham S; Loos D; Stumpfe S; Lohmann C; Maier M; Feucht N
Ophthalmologe; 2015 Oct; 112(10):857-60. PubMed ID: 25680347
[TBL] [Abstract][Full Text] [Related]
2. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Agarwal M; Ganesh SK; Biswas J
Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
[TBL] [Abstract][Full Text] [Related]
3. The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease.
Kim SJ; Yu HG
Ocul Immunol Inflamm; 2007; 15(5):381-7. PubMed ID: 17972222
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Martin TD; Rathinam SR; Cunningham ET
Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
[TBL] [Abstract][Full Text] [Related]
5. [Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
Kohnen EM; Pansdorf Y; Zubcov A
Ophthalmologe; 2004 Apr; 101(4):390-3. PubMed ID: 15067421
[No Abstract] [Full Text] [Related]
6. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
7. [Vogt Koyanagi Harada syndrome in children: diagnosis and management].
Benfdil N; Baha Ali T; Jellab B; Moutaouakil A
Bull Soc Belge Ophtalmol; 2010; (314):15-8. PubMed ID: 20480746
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada syndrome: importance of early treatment.
Radic B; Vukojevic N; Petelin Gadze Z; Dapic Ivancic B; Barun B
Acta Neurol Belg; 2020 Oct; 120(5):1217-1219. PubMed ID: 31927745
[No Abstract] [Full Text] [Related]
9. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
[TBL] [Abstract][Full Text] [Related]
10. [Vogt-Koyanagi-Harada syndrome in children].
Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study.
Ingolotti M; Schlaen BA; Roig Melo-Granados EA; Ruiz García H; Aguilera Partida JA
Am J Case Rep; 2019 Mar; 20():300-305. PubMed ID: 30842390
[TBL] [Abstract][Full Text] [Related]
12. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Accorinti M; Saturno MC; Manni P
Ocul Immunol Inflamm; 2022 Jul; 30(5):1228-1233. PubMed ID: 35201950
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
Cuchacovich M; Solanes F; Díaz G; Cermenati T; Avila S; Verdaguer J; Verdaguer JI; Carpentier C; Stopel J; Rojas B; Traipe L; Gallardo P; Sabugo F; Zanoli M; Merino G; Villarroel F
Ocul Immunol Inflamm; 2010 Jun; 18(3):200-7. PubMed ID: 20482399
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus retinitis following corticosteroid overdose for Vogt-Koyanagi-Harada disease.
Khochtali S; Mahjoub A; Dridi T; Ksiaa I; Abroug N; Khairallah M
Indian J Ophthalmol; 2020 Sep; 68(9):2012-2014. PubMed ID: 32823462
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of Vogt-Koyanagi-Harada-syndrome (uveoencephalitis) (author's transl)].
Sundmacher R
Klin Monbl Augenheilkd; 1975 Apr; 166(4):540-6. PubMed ID: 1206928
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada syndrome.
Hammer H; Janáky M; Süveges I
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):711-3. PubMed ID: 8109221
[TBL] [Abstract][Full Text] [Related]
17. Melanin-laden macrophages in the CSF to diagnose Vogt-Koyanagi-Harada simulating ocular syphilis.
Kim LA; Khurana RN; Parikh JG; Rao NA
Ocul Immunol Inflamm; 2008; 16(1):59-61. PubMed ID: 18379946
[TBL] [Abstract][Full Text] [Related]
18. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome.
Rubsamen PE; Gass JD
Arch Ophthalmol; 1991 May; 109(5):682-7. PubMed ID: 2025171
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
20. [Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome].
Rodríguez Rivera V; Garrigues HP; Gallego Pinazo R
Acta Otorrinolaringol Esp; 2011; 62(6):465-8. PubMed ID: 21167466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
